Current Trends in Monoclonal Antibody Development and Manufacturing



de

, , ,

Éditeur :

Springer


Collection :

Biotechnology: Pharmaceutical Aspects

Paru le : 2009-11-11



eBook Téléchargement , DRM LCP 🛈 DRM Adobe 🛈
Lecture en ligne (streaming)
210,99

Téléchargement immédiat
Dès validation de votre commande
Ajouter à ma liste d'envies
Image Louise Reader présentation

Louise Reader

Lisez ce titre sur l'application Louise Reader.

Description
Monoclonal antibodies represent one of the fastest growing areas of new drug development within the pharmaceutical industry. Several blockbuster products have been approved over the past several years including Rituxan, Remicade, Avastin, Humira, and Herceptin. In addition, over 300 new drugs are currently in clinical trials. With both large, established biotechnology companies and small start-ups involved in the development of this important class of molecules, monoclonal antibodies products will become increasingly prevalent over the next decade. Recently the regulatory review of monoclonal antibodies has been moved from Center for Biologics and Research to the Center for Drug Evaluation and Research (CDER) division of the US Food and Drug Administration. It is anticipated that CDER will expect a certain minimal amount of data to be provided as more of these products move through the regulatory pipeline. Current Trends in Monoclonal Antibody Development and Manufacturing will provide readers with an understanding of what is currently being done in the industry to develop, manufacture, and release monoclonal antibody products and what will be required for a successful regulatory submission.
Pages
354 pages
Collection
Biotechnology: Pharmaceutical Aspects
Parution
2009-11-11
Marque
Springer
EAN papier
9780387766423
EAN EPUB
9780387766430

Informations sur l'ebook
Nombre pages copiables
3
Nombre pages imprimables
35
Taille du fichier
3512 Ko
Prix
210,99 €